Menu
GeneBe

ATP2B1

ATPase plasma membrane Ca2+ transporting 1, the group of ATPases Ca2+ transporting

Basic information

Region (hg38): 12:89588048-89709366

Links

ENSG00000070961NCBI:490OMIM:108731HGNC:814Uniprot:P20020AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual developmental disorder, autosomal dominant 66 (Moderate), mode of inheritance: AD
  • intellectual developmental disorder, autosomal dominant 66 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, autosomal dominant 66ADGeneralAmong other findings, the condition can involve congenital heart anomalies, and awareness may allow prompt diagnosis and managementCardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Neurologic35358416

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ATP2B1 gene.

  • Inborn genetic diseases (27 variants)
  • not provided (22 variants)
  • Intellectual developmental disorder, autosomal dominant 66 (14 variants)
  • Neurodevelopmental disorder (13 variants)
  • not specified (3 variants)
  • ATP2B1-related condition (2 variants)
  • Isolated Pierre-Robin syndrome;Neurodevelopmental delay;Clubfoot;Periventricular nodular heterotopia;Hypocalcemia (2 variants)
  • Intellectual disability, autosomal dominant 30 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP2B1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
2
clinvar
4
clinvar
7
missense
1
clinvar
8
clinvar
45
clinvar
54
nonsense
2
clinvar
4
clinvar
2
clinvar
8
start loss
0
frameshift
1
clinvar
2
clinvar
1
clinvar
4
inframe indel
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
0
non coding
0
Total 4 17 50 2 4

Highest pathogenic variant AF is 0.00000657

Variants in ATP2B1

This is a list of pathogenic ClinVar variants found in the ATP2B1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-89591012-G-A Uncertain significance (Nov 01, 2023)2672513
12-89591015-C-A Intellectual developmental disorder, autosomal dominant 66 Uncertain significance (Aug 01, 2022)1710505
12-89591090-T-C Uncertain significance (Nov 28, 2022)2503359
12-89591097-T-C Inborn genetic diseases Uncertain significance (May 15, 2023)2530336
12-89591106-G-T Inborn genetic diseases Uncertain significance (Sep 14, 2021)2369762
12-89591108-G-T Inborn genetic diseases Uncertain significance (Jul 06, 2021)2333279
12-89591192-A-G not specified Uncertain significance (Mar 08, 2024)3233557
12-89591194-C-G Uncertain significance (Aug 16, 2022)2095912
12-89591227-C-A Benign (Aug 16, 2018)784251
12-89591280-C-A Intellectual developmental disorder, autosomal dominant 66 Uncertain significance (Feb 23, 2023)2444387
12-89599230-C-T Inborn genetic diseases Uncertain significance (Apr 12, 2022)2378385
12-89601384-G-C Neurodevelopmental disorder Likely pathogenic (Aug 29, 2022)2627844
12-89603041-A-C Neurodevelopmental delay;Hypocalcemia;Isolated Pierre-Robin syndrome;Clubfoot;Periventricular nodular heterotopia Likely pathogenic (Jan 12, 2022)1334402
12-89603048-C-G not specified Uncertain significance (Aug 25, 2023)2581374
12-89603068-A-G Inborn genetic diseases Uncertain significance (Nov 08, 2022)2323474
12-89603103-G-T Inborn genetic diseases Uncertain significance (Aug 16, 2021)2245376
12-89603131-C-T Neurodevelopmental disorder Likely pathogenic (Apr 11, 2022)1679164
12-89603144-C-A Intellectual disability, autosomal dominant 30 Likely pathogenic (-)2580931
12-89603165-C-A Neurodevelopmental delay;Hypocalcemia;Isolated Pierre-Robin syndrome;Clubfoot;Periventricular nodular heterotopia Likely pathogenic (Jan 12, 2022)1334403
12-89603210-G-C Inborn genetic diseases Uncertain significance (Dec 29, 2022)2328352
12-89603718-A-T Inborn genetic diseases Uncertain significance (Sep 23, 2023)3131532
12-89603741-A-C Uncertain significance (Dec 13, 2022)2505715
12-89603754-C-T Inborn genetic diseases Uncertain significance (Jun 13, 2023)2559878
12-89603811-A-G Uncertain significance (Jul 15, 2022)1878884
12-89603919-G-T Uncertain significance (Jul 06, 2022)1810713

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ATP2B1protein_codingprotein_codingENST00000428670 20121250
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.006.69e-9125731061257370.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense5.292716510.4160.00003327990
Missense in Polyphen86309.610.277773785
Synonymous1.052022220.9100.00001142366
Loss of Function6.83156.30.01780.00000305719

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004630.0000462
European (Non-Finnish)0.00003650.0000352
Middle Eastern0.00005440.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium out of the cell.;
Pathway
Aldosterone synthesis and secretion - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human);Salivary secretion - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Mineral absorption - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Vitamin D Receptor Pathway;Splicing factor NOVA regulated synaptic proteins;Calcium Regulation in the Cardiac Cell;Ion channel transport;Purine metabolism;Ion homeostasis;Transport of small molecules;Cardiac conduction;Muscle contraction;Ion transport by P-type ATPases;Hemostasis;C-MYB transcription factor network;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Platelet homeostasis (Consensus)

Recessive Scores

pRec
0.230

Intolerance Scores

loftool
0.00551
rvis_EVS
-1.02
rvis_percentile_EVS
7.94

Haploinsufficiency Scores

pHI
0.932
hipred
Y
hipred_score
0.768
ghis
0.625

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.814

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Atp2b1
Phenotype
limbs/digits/tail phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
atp2b1a
Affected structure
neuromast hair cell
Phenotype tag
abnormal
Phenotype quality
has fewer parts of type

Gene ontology

Biological process
neural retina development;cellular calcium ion homeostasis;brain development;aging;response to cold;ion transmembrane transport;regulation of cytosolic calcium ion concentration;calcium ion transmembrane transport;cellular response to vitamin D;cellular response to corticosterone stimulus;ATP hydrolysis coupled cation transmembrane transport;regulation of presynaptic cytosolic calcium ion concentration;regulation of cardiac conduction;calcium ion export across plasma membrane
Cellular component
nucleus;plasma membrane;integral component of plasma membrane;cytoplasmic side of plasma membrane;membrane;basolateral plasma membrane;apical plasma membrane;dendritic spine membrane;neuronal cell body membrane;membrane raft;extracellular exosome;glutamatergic synapse;GABA-ergic synapse;integral component of presynaptic active zone membrane
Molecular function
calcium-transporting ATPase activity;protein binding;calmodulin binding;ATP binding;calcium ion transmembrane transporter activity;PDZ domain binding;metal ion binding;calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration